首页> 外文期刊>The Journal of biological chemistry >Mechanism of Down-regulation of RNA Polymerase III-transcribed Non-coding RNA Genes in Macrophages by Leishmania
【24h】

Mechanism of Down-regulation of RNA Polymerase III-transcribed Non-coding RNA Genes in Macrophages by Leishmania

机译:LeishMania巨噬细胞中RNA聚合酶III转录的非编码RNA基因的解调机制

获取原文
           

摘要

The parasitic protozoan Leishmania invades mammalian macrophages to establish infection. We reported previously that Leishmania manipulates the expression of several non-coding RNA genes (e.g. Alu RNA, B1 RNA, and signal recognition particle RNA) in macrophages to favor the establishment of their infection in the phagolysosomes of these cells (Ueda, Y., and Chaudhuri, G. (2000) J. Biol. Chem. 275, 19428–19432; Misra, S., Tripathi, M. K., and Chaudhuri, G. (2005) J. Biol. Chem. 280, 29364–29373). We report here the mechanism of this down-regulation. We found that the non-coding RNA (ncRNA) genes that are repressed by Leishmania infection in macrophages contain a “B-box” in their promoters and thus require the polymerase III transcription factor TFIIIC for their expression. We also found that Leishmania promastigotes through their surface protease (leishmanolysin or gp63) activate the thrombin receptor PAR1 in the macrophages. This activation of PAR1 raised the cytosolic concentration of Ca2+ into the micromolar range, thereby activating the Ca2+-dependent protease μ-calpain. μ-Calpain then degraded TFIIIC110 to inhibit the expression of the selected ncRNA genes. Avirulent stocks of Leishmania not expressing surface gp63 failed to down-regulate ncRNAs in the exposed macrophages. Inhibition of PAR1 or calpain 1 in macrophages made them resistant to Leishmania infection. These data suggest that macrophage PAR1 and calpain 1 are potential drug targets against leishmaniasis.
机译:寄生原生动物Leishmania侵犯哺乳动物巨噬细胞建立感染。我们以前报道了Leishmania在巨噬细胞中操纵若干非编码RNA基因(例如Alu RNA,B1 RNA和信号识别粒子RNA)的表达,以便在这些细胞的吞噬细胞中建立它们的感染(UEDA,Y.,和Chaudhuri,G.(2000)J. Biol.Chem。Chem。275,19428-19432; Misra,S.,Tripathi,MK和Chaudhuri,G.(2005)J. Biol。化学。280,29364-29373)。我们在此报告此下调的机制。我们发现,在巨噬细胞中被Leishmania感染抑制的非编码RNA(NCRNA)基因在其启动子中含有“B盒”,因此需要聚合酶III转录因子TFIIC以其表达。我们还发现Leishmania突出通过其表面蛋白酶(LeishManolysin或GP63)在巨噬细胞中激活凝血酶受体PAR1。 PAR1的这种激活将Ca2 +的细胞溶胶浓度提高到微摩尔范围内,从而激活Ca2 +依赖性蛋白酶μ-calpain。然后降解TFIIIC110以抑制所选NCRNA基因的表达。 Leishmania的无毒股未表达表面GP63未能在暴露的巨噬细胞中降低NCRNA。在巨噬细胞中对Par1或Calpain 1的抑制使其耐受Leishmania感染。这些数据表明,巨噬细胞Par1和Calpain 1是针对Leishmaniaisis的潜在药物目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号